Patrocinado
Nirmatrelvir INN + Ritonavir USP

Nirmatrelvir INN + Ritonavir USP is a combination drug used to treat COVID-19 infection (SARS-CoV-2), a virus that can cause severe illnesses. The two medications are combined in a pink, film-coated tablet. They are taken twice a day for five days.

In Canada, the two drugs were licensed for treating adult COVID-19 patients. Patients must be at risk for complications from the disease. This includes older people, people with immune system problems, and Indigenous people. EPIC-HR is a study of Nirmatrelvir/ritonavir in patients who have mild COVID-19. In this study, the treatment decreased the risk of hospitalization by 5.5%. It also prevented one death for every 87 people treated.

Although the trial is a clinical trial, it is not yet peer-reviewed. It is not recommended for people under 40 kg. However, the FDA has approved for emergency use of this medication.
To avoid serious medical complications, people who need extra oxygen should have their COVID-19 infections treated. This is usually done in a hospital. Other treatments can work better. While nirmatrelvir/ritonavir may help, it is important to consult your doctor if you need additional treatment.

Patients who take ritonavir in combination with nirmatrelvir should be monitored carefully for signs of liver disease. This can include increased PT and alanine aminotransferase. People with kidney disease should avoid nirmatrelvir. Nirmatrelvir/ritonavir has been evaluated in several animal models. In vivo studies have demonstrated that the medication has negative clastogenic and mutagenic activity. Animal reproduction studies have also shown that nirmatrelvir has no effects on the early embryonic development of animals.

To know more: https://www.gnhindia.com/products/pax-power-nirmatrelvir-inn-ritonavir-usp/
Nirmatrelvir INN + Ritonavir USP Nirmatrelvir INN + Ritonavir USP is a combination drug used to treat COVID-19 infection (SARS-CoV-2), a virus that can cause severe illnesses. The two medications are combined in a pink, film-coated tablet. They are taken twice a day for five days. In Canada, the two drugs were licensed for treating adult COVID-19 patients. Patients must be at risk for complications from the disease. This includes older people, people with immune system problems, and Indigenous people. EPIC-HR is a study of Nirmatrelvir/ritonavir in patients who have mild COVID-19. In this study, the treatment decreased the risk of hospitalization by 5.5%. It also prevented one death for every 87 people treated. Although the trial is a clinical trial, it is not yet peer-reviewed. It is not recommended for people under 40 kg. However, the FDA has approved for emergency use of this medication. To avoid serious medical complications, people who need extra oxygen should have their COVID-19 infections treated. This is usually done in a hospital. Other treatments can work better. While nirmatrelvir/ritonavir may help, it is important to consult your doctor if you need additional treatment. Patients who take ritonavir in combination with nirmatrelvir should be monitored carefully for signs of liver disease. This can include increased PT and alanine aminotransferase. People with kidney disease should avoid nirmatrelvir. Nirmatrelvir/ritonavir has been evaluated in several animal models. In vivo studies have demonstrated that the medication has negative clastogenic and mutagenic activity. Animal reproduction studies have also shown that nirmatrelvir has no effects on the early embryonic development of animals. To know more: https://www.gnhindia.com/products/pax-power-nirmatrelvir-inn-ritonavir-usp/
WWW.GNHINDIA.COM
Pax-Power - Nirmatrelvir INN + Ritonavir USP
Buy Pax-Power - Nirmatrelvir INN + Ritonavir 150mg (2 blister) + 100mg (1 blister) by GNH India Pharmaceuticals Limited. Get quick delivery of medicines online from GNH India at the best price. GNH India is a Global Pharmaceuticals Distributor with shipping to over 180 countries globally.
0 Comentários 0 Compartilhamentos 473 Visualizações
Patrocinado

Instant Money Transfers - Open Free Account

Mobile Money made easy, all currencies

Patrocinado